

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.37965845 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.37965845 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.12167478 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.68080168 |
| 5 | cellular response to type I interferon (GO:0071357) | 5.62920576 |
| 6 | type I interferon signaling pathway (GO:0060337) | 5.62920576 |
| 7 | response to type I interferon (GO:0034340) | 5.62287462 |
| 8 | positive regulation of interferon-alpha production (GO:0032727) | 5.47529327 |
| 9 | regulation of interferon-alpha production (GO:0032647) | 5.18603845 |
| 10 | response to interferon-alpha (GO:0035455) | 5.04181110 |
| 11 | regulation of vitamin metabolic process (GO:0030656) | 4.71763388 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.56854503 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.56854503 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 4.56854503 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 4.56854503 |
| 16 | modulation by symbiont of host defense response (GO:0052031) | 4.56854503 |
| 17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.56854503 |
| 18 | cellular response to interferon-beta (GO:0035458) | 4.48924332 |
| 19 | cellular response to interferon-alpha (GO:0035457) | 4.34455744 |
| 20 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.31193975 |
| 21 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.23418990 |
| 22 | neutrophil activation involved in immune response (GO:0002283) | 4.20376265 |
| 23 | response to interferon-beta (GO:0035456) | 4.15659738 |
| 24 | response to peptidoglycan (GO:0032494) | 4.14052591 |
| 25 | negative regulation of viral genome replication (GO:0045071) | 4.11034539 |
| 26 | cellular response to exogenous dsRNA (GO:0071360) | 4.00809005 |
| 27 | immunoglobulin mediated immune response (GO:0016064) | 4.00100314 |
| 28 | positive regulation of interferon-beta production (GO:0032728) | 3.91541795 |
| 29 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.90691843 |
| 30 | angiotensin maturation (GO:0002003) | 3.88341206 |
| 31 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.87499847 |
| 32 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.85237631 |
| 33 | regulation of RIG-I signaling pathway (GO:0039535) | 3.83820342 |
| 34 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.82383371 |
| 35 | T cell migration (GO:0072678) | 3.73306627 |
| 36 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.70331088 |
| 37 | T-helper 1 type immune response (GO:0042088) | 3.67277124 |
| 38 | defense response to protozoan (GO:0042832) | 3.67000584 |
| 39 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.66125111 |
| 40 | macrophage activation involved in immune response (GO:0002281) | 3.62324747 |
| 41 | cellular response to virus (GO:0098586) | 3.61019589 |
| 42 | positive regulation of type 2 immune response (GO:0002830) | 3.60311134 |
| 43 | respiratory burst (GO:0045730) | 3.58291080 |
| 44 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.50986354 |
| 45 | cellular response to interferon-gamma (GO:0071346) | 3.49193106 |
| 46 | negative regulation of cell killing (GO:0031342) | 3.48768048 |
| 47 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.48768048 |
| 48 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.48125668 |
| 49 | positive regulation of antigen processing and presentation (GO:0002579) | 3.46584691 |
| 50 | natural killer cell mediated immunity (GO:0002228) | 3.46387241 |
| 51 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.46387241 |
| 52 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.43458992 |
| 53 | response to host immune response (GO:0052572) | 3.43458992 |
| 54 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.43005426 |
| 55 | response to muramyl dipeptide (GO:0032495) | 3.32524990 |
| 56 | positive regulation of interleukin-12 production (GO:0032735) | 3.32315387 |
| 57 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.31524178 |
| 58 | response to protozoan (GO:0001562) | 3.28563909 |
| 59 | positive regulation of tolerance induction (GO:0002645) | 3.27529769 |
| 60 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.25827312 |
| 61 | * defense response to virus (GO:0051607) | 3.24122145 |
| 62 | myeloid dendritic cell differentiation (GO:0043011) | 3.23871362 |
| 63 | granulocyte activation (GO:0036230) | 3.22354800 |
| 64 | lymphocyte chemotaxis (GO:0048247) | 3.20473394 |
| 65 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.19298523 |
| 66 | regulation of T cell tolerance induction (GO:0002664) | 3.19047744 |
| 67 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.18531347 |
| 68 | regulation of tolerance induction (GO:0002643) | 3.17318547 |
| 69 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.15575378 |
| 70 | neutrophil activation (GO:0042119) | 3.15153792 |
| 71 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.14256032 |
| 72 | response to interferon-gamma (GO:0034341) | 3.12203793 |
| 73 | regulation of cellular extravasation (GO:0002691) | 3.11898947 |
| 74 | cellular response to zinc ion (GO:0071294) | 3.11272470 |
| 75 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.10755581 |
| 76 | regulation of activation of Janus kinase activity (GO:0010533) | 3.10455926 |
| 77 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.09993125 |
| 78 | virion attachment to host cell (GO:0019062) | 3.09872783 |
| 79 | adhesion of symbiont to host cell (GO:0044650) | 3.09872783 |
| 80 | myeloid dendritic cell activation (GO:0001773) | 3.08316886 |
| 81 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.07634717 |
| 82 | response to host (GO:0075136) | 3.07634717 |
| 83 | response to host defenses (GO:0052200) | 3.07634717 |
| 84 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.06802956 |
| 85 | regulation of antigen processing and presentation (GO:0002577) | 3.04357936 |
| 86 | B cell mediated immunity (GO:0019724) | 3.04121380 |
| 87 | positive regulation of T cell cytokine production (GO:0002726) | 3.00758177 |
| 88 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.99427768 |
| 89 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.98918713 |
| 90 | reactive oxygen species biosynthetic process (GO:1903409) | 2.98141128 |
| 91 | regulation of chemokine biosynthetic process (GO:0045073) | 2.96529380 |
| 92 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.96291779 |
| 93 | myeloid cell activation involved in immune response (GO:0002275) | 2.94581768 |
| 94 | regulation of regulatory T cell differentiation (GO:0045589) | 2.93419846 |
| 95 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.91868683 |
| 96 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.91550989 |
| 97 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.91318189 |
| 98 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.90500601 |
| 99 | positive regulation of response to biotic stimulus (GO:0002833) | 2.90115687 |
| 100 | regulation of interferon-beta production (GO:0032648) | 2.89301790 |
| 101 | leukocyte mediated cytotoxicity (GO:0001909) | 2.87673474 |
| 102 | detection of molecule of bacterial origin (GO:0032490) | 2.87027303 |
| 103 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.84084624 |
| 104 | positive regulation of defense response to virus by host (GO:0002230) | 2.82377521 |
| 105 | positive regulation of interleukin-17 production (GO:0032740) | 2.82259443 |
| 106 | response to exogenous dsRNA (GO:0043330) | 2.81321158 |
| 107 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.79762132 |
| 108 | regulation of interleukin-12 production (GO:0032655) | 2.78503247 |
| 109 | monocyte chemotaxis (GO:0002548) | 2.76886692 |
| 110 | microglial cell activation (GO:0001774) | 2.76610575 |
| 111 | detection of other organism (GO:0098543) | 2.76426696 |
| 112 | negative regulation of interleukin-17 production (GO:0032700) | 2.74841205 |
| 113 | regulation of response to interferon-gamma (GO:0060330) | 2.74531800 |
| 114 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.73152689 |
| 115 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.71691059 |
| 116 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.71567700 |
| 117 | NIK/NF-kappaB signaling (GO:0038061) | 2.70570938 |
| 118 | JAK-STAT cascade (GO:0007259) | 2.68316912 |
| 119 | eosinophil chemotaxis (GO:0048245) | 2.68219103 |
| 120 | detection of bacterium (GO:0016045) | 2.67244415 |
| 121 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.66465488 |
| 122 | cytidine deamination (GO:0009972) | 2.57192290 |
| 123 | cytidine metabolic process (GO:0046087) | 2.57192290 |
| 124 | cytidine catabolic process (GO:0006216) | 2.57192290 |
| 125 | negative regulation of interleukin-12 production (GO:0032695) | 2.56274463 |
| 126 | regulation of mononuclear cell migration (GO:0071675) | 2.54775880 |
| 127 | intestinal absorption (GO:0050892) | 2.52361034 |
| 128 | peptide catabolic process (GO:0043171) | 2.49157879 |
| 129 | adhesion of symbiont to host (GO:0044406) | 2.47602791 |
| 130 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.46905433 |
| 131 | epoxygenase P450 pathway (GO:0019373) | 2.46534134 |
| 132 | regulation of gamma-delta T cell activation (GO:0046643) | 2.46254091 |
| 133 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.45913023 |
| 134 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.45156329 |
| 135 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.45156329 |
| 136 | T cell costimulation (GO:0031295) | 2.42796168 |
| 137 | detection of external biotic stimulus (GO:0098581) | 2.40070475 |
| 138 | lymphocyte costimulation (GO:0031294) | 2.38855416 |
| 139 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.37813816 |
| 140 | lipoprotein transport (GO:0042953) | 2.36810859 |
| 141 | regulation of type 2 immune response (GO:0002828) | 2.36185321 |
| 142 | positive regulation of cell killing (GO:0031343) | 2.35591857 |
| 143 | regulation of cell killing (GO:0031341) | 2.35173954 |
| 144 | eosinophil migration (GO:0072677) | 2.34621170 |
| 145 | interferon-gamma secretion (GO:0072643) | 2.34074130 |
| 146 | leukocyte aggregation (GO:0070486) | 2.31067280 |
| 147 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.30755957 |
| 148 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.26352608 |
| 149 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.26208524 |
| 150 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.24692222 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 8.34113217 |
| 2 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.72479168 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 6.47063521 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.24345172 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.88047005 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.54480273 |
| 7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.11298643 |
| 8 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.49466239 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.48520866 |
| 10 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.36599011 |
| 11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.14280974 |
| 12 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.00089444 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.97506976 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.96678369 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.96113364 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.76158574 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.68976791 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.65887537 |
| 19 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.22040885 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.20476930 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.09057781 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.04474977 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 1.97854634 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.86344602 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 1.80805954 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.80295116 |
| 27 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.76000119 |
| 28 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.75781261 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.73723913 |
| 30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.65440064 |
| 31 | MYB_26560356_Chip-Seq_TH1_Human | 1.61249776 |
| 32 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.57495222 |
| 33 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.56554340 |
| 34 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.55007534 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50295624 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.50217561 |
| 37 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.50108064 |
| 38 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.49755073 |
| 39 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.47597032 |
| 40 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.45114091 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.44461111 |
| 42 | SPI1_23127762_ChIP-Seq_K562_Human | 1.44387476 |
| 43 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42433500 |
| 44 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.42369236 |
| 45 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41147224 |
| 46 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.41029779 |
| 47 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39777872 |
| 48 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.34560729 |
| 49 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.33192454 |
| 50 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.31540429 |
| 51 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.30210218 |
| 52 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.29912551 |
| 53 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.27077292 |
| 54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.26860346 |
| 55 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.20617815 |
| 56 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19556030 |
| 57 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.18572667 |
| 58 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16771423 |
| 59 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.16548290 |
| 60 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.14676575 |
| 61 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.13925150 |
| 62 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13871457 |
| 63 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13525442 |
| 64 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.12856717 |
| 65 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.12783190 |
| 66 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.12665701 |
| 67 | UTX_26944678_Chip-Seq_JUKART_Human | 1.11853995 |
| 68 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09100172 |
| 69 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.08963918 |
| 70 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.08474528 |
| 71 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08359776 |
| 72 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07830272 |
| 73 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.05853148 |
| 74 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05749170 |
| 75 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04802431 |
| 76 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03624931 |
| 77 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03041763 |
| 78 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02610552 |
| 79 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.01717068 |
| 80 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01397484 |
| 81 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01266943 |
| 82 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00341800 |
| 83 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98696388 |
| 84 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.98300906 |
| 85 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.92414954 |
| 86 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92289364 |
| 87 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.92199527 |
| 88 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.91416195 |
| 89 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.91206997 |
| 90 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90814008 |
| 91 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.90602341 |
| 92 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.90581915 |
| 93 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90397892 |
| 94 | * MAF_26560356_Chip-Seq_TH2_Human | 0.89201057 |
| 95 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.89114252 |
| 96 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85922714 |
| 97 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.85472009 |
| 98 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84388378 |
| 99 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.78495555 |
| 100 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.78215928 |
| 101 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78073727 |
| 102 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.77554752 |
| 103 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.76397957 |
| 104 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.73641259 |
| 105 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.72847337 |
| 106 | GATA2_19941826_ChIP-Seq_K562_Human | 0.70188398 |
| 107 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.67810741 |
| 108 | GATA1_19941826_ChIP-Seq_K562_Human | 0.66846215 |
| 109 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.66303822 |
| 110 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.66303822 |
| 111 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.64913636 |
| 112 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.64897016 |
| 113 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.63103047 |
| 114 | MYC_22102868_ChIP-Seq_BL_Human | 0.62160685 |
| 115 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.61014014 |
| 116 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.60849749 |
| 117 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.60730658 |
| 118 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.60228907 |
| 119 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.59585808 |
| 120 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.59585808 |
| 121 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.59115536 |
| 122 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.58709831 |
| 123 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.58690224 |
| 124 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.58660749 |
| 125 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.58252330 |
| 126 | CJUN_26792858_Chip-Seq_BT549_Human | 0.57456109 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.84474635 |
| 2 | MP0009785_altered_susceptibility_to | 4.13430954 |
| 3 | MP0003724_increased_susceptibility_to | 3.88657604 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.35392614 |
| 5 | MP0003436_decreased_susceptibility_to | 3.25272534 |
| 6 | MP0000685_abnormal_immune_system | 3.13687251 |
| 7 | MP0001790_abnormal_immune_system | 3.12134116 |
| 8 | MP0005387_immune_system_phenotype | 3.12134116 |
| 9 | MP0005360_urolithiasis | 3.11442531 |
| 10 | MP0005025_abnormal_response_to | 3.10661975 |
| 11 | MP0005000_abnormal_immune_tolerance | 3.05724055 |
| 12 | MP0006082_CNS_inflammation | 3.04795865 |
| 13 | MP0003303_peritoneal_inflammation | 3.00580575 |
| 14 | MP0005671_abnormal_response_to | 3.00391464 |
| 15 | MP0002419_abnormal_innate_immunity | 2.82844387 |
| 16 | MP0001800_abnormal_humoral_immune | 2.71588616 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.65914870 |
| 18 | MP0004510_myositis | 2.58594183 |
| 19 | MP0002723_abnormal_immune_serum | 2.57340733 |
| 20 | MP0002139_abnormal_hepatobiliary_system | 2.29026098 |
| 21 | MP0001819_abnormal_immune_cell | 2.28615448 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.24321886 |
| 23 | MP0002006_tumorigenesis | 2.23044244 |
| 24 | MP0002166_altered_tumor_susceptibility | 2.15095607 |
| 25 | MP0001533_abnormal_skeleton_physiology | 2.05309913 |
| 26 | MP0001853_heart_inflammation | 2.04726532 |
| 27 | MP0004947_skin_inflammation | 1.95833079 |
| 28 | MP0009764_decreased_sensitivity_to | 1.90135675 |
| 29 | MP0005058_abnormal_lysosome_morphology | 1.88698275 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.87884171 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.85947275 |
| 32 | MP0005085_abnormal_gallbladder_physiolo | 1.83028112 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.82828937 |
| 34 | MP0008469_abnormal_protein_level | 1.74746726 |
| 35 | MP0003448_altered_tumor_morphology | 1.73457614 |
| 36 | MP0000716_abnormal_immune_system | 1.72675604 |
| 37 | MP0000343_altered_response_to | 1.69037120 |
| 38 | MP0002398_abnormal_bone_marrow | 1.68029907 |
| 39 | MP0002405_respiratory_system_inflammati | 1.66935342 |
| 40 | MP0001666_abnormal_nutrient_absorption | 1.66674656 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.59639247 |
| 42 | MP0009278_abnormal_bone_marrow | 1.58270244 |
| 43 | MP0003075_altered_response_to | 1.56953457 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.56528285 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.56528285 |
| 46 | MP0003300_gastrointestinal_ulcer | 1.55049771 |
| 47 | MP0005365_abnormal_bile_salt | 1.53110262 |
| 48 | MP0005167_abnormal_blood-brain_barrier | 1.53103826 |
| 49 | MP0009780_abnormal_chondrocyte_physiolo | 1.41304554 |
| 50 | MP0002429_abnormal_blood_cell | 1.39083289 |
| 51 | MP0002998_abnormal_bone_remodeling | 1.35655931 |
| 52 | MP0000689_abnormal_spleen_morphology | 1.35288422 |
| 53 | MP0003763_abnormal_thymus_physiology | 1.34490659 |
| 54 | MP0003191_abnormal_cellular_cholesterol | 1.33103644 |
| 55 | MP0000858_altered_metastatic_potential | 1.27366271 |
| 56 | MP0002722_abnormal_immune_system | 1.27305587 |
| 57 | MP0010368_abnormal_lymphatic_system | 1.25526496 |
| 58 | MP0001879_abnormal_lymphatic_vessel | 1.21681353 |
| 59 | MP0005310_abnormal_salivary_gland | 1.21645947 |
| 60 | MP0003806_abnormal_nucleotide_metabolis | 1.20962392 |
| 61 | MP0004019_abnormal_vitamin_homeostasis | 1.17155777 |
| 62 | MP0008004_abnormal_stomach_pH | 1.14319341 |
| 63 | MP0001663_abnormal_digestive_system | 1.14197118 |
| 64 | MP0009643_abnormal_urine_homeostasis | 1.12884019 |
| 65 | MP0008438_abnormal_cutaneous_collagen | 1.12710831 |
| 66 | MP0004808_abnormal_hematopoietic_stem | 1.12090880 |
| 67 | MP0009763_increased_sensitivity_to | 1.11848129 |
| 68 | MP0003186_abnormal_redox_activity | 1.10673342 |
| 69 | MP0003252_abnormal_bile_duct | 1.09996827 |
| 70 | MP0005164_abnormal_response_to | 1.09365988 |
| 71 | MP0003172_abnormal_lysosome_physiology | 1.08112737 |
| 72 | MP0004264_abnormal_extraembryonic_tissu | 1.07510912 |
| 73 | MP0005166_decreased_susceptibility_to | 1.07077916 |
| 74 | MP0002138_abnormal_hepatobiliary_system | 1.03744426 |
| 75 | MP0000604_amyloidosis | 1.01158642 |
| 76 | MP0004883_abnormal_blood_vessel | 1.01024871 |
| 77 | MP0003091_abnormal_cell_migration | 0.98238079 |
| 78 | MP0004782_abnormal_surfactant_physiolog | 0.97900018 |
| 79 | MP0003828_pulmonary_edema | 0.97485930 |
| 80 | MP0001542_abnormal_bone_strength | 0.96629707 |
| 81 | MP0010307_abnormal_tumor_latency | 0.96611786 |
| 82 | MP0010234_abnormal_vibrissa_follicle | 0.96590181 |
| 83 | MP0000249_abnormal_blood_vessel | 0.95366927 |
| 84 | MP0005390_skeleton_phenotype | 0.95060087 |
| 85 | MP0002254_reproductive_system_inflammat | 0.94111747 |
| 86 | MP0005451_abnormal_body_composition | 0.91159329 |
| 87 | MP0009840_abnormal_foam_cell | 0.89845287 |
| 88 | MP0008875_abnormal_xenobiotic_pharmacok | 0.89824336 |
| 89 | MP0001851_eye_inflammation | 0.88055884 |
| 90 | MP0002933_joint_inflammation | 0.87667069 |
| 91 | MP0001765_abnormal_ion_homeostasis | 0.87138798 |
| 92 | MP0001873_stomach_inflammation | 0.86924477 |
| 93 | MP0003045_fibrosis | 0.85754398 |
| 94 | MP0003950_abnormal_plasma_membrane | 0.83918831 |
| 95 | MP0003690_abnormal_glial_cell | 0.83683005 |
| 96 | MP0003566_abnormal_cell_adhesion | 0.82850949 |
| 97 | MP0008260_abnormal_autophagy | 0.82839342 |
| 98 | MP0002396_abnormal_hematopoietic_system | 0.82202930 |
| 99 | MP0001958_emphysema | 0.81489976 |
| 100 | MP0005381_digestive/alimentary_phenotyp | 0.79362030 |
| 101 | MP0005275_abnormal_skin_tensile | 0.78446396 |
| 102 | MP0000767_abnormal_smooth_muscle | 0.77942128 |
| 103 | MP0001664_abnormal_digestion | 0.77505377 |
| 104 | MP0005023_abnormal_wound_healing | 0.74733959 |
| 105 | MP0000703_abnormal_thymus_morphology | 0.74658785 |
| 106 | MP0002136_abnormal_kidney_physiology | 0.73359930 |
| 107 | MP0003453_abnormal_keratinocyte_physiol | 0.73358645 |
| 108 | MP0000465_gastrointestinal_hemorrhage | 0.70397894 |
| 109 | MP0003183_abnormal_peptide_metabolism | 0.69633992 |
| 110 | MP0010352_gastrointestinal_tract_polyps | 0.66684984 |
| 111 | MP0002277_abnormal_respiratory_mucosa | 0.64779878 |
| 112 | MP0003705_abnormal_hypodermis_morpholog | 0.63392409 |
| 113 | MP0003866_abnormal_defecation | 0.61121718 |
| 114 | MP0003795_abnormal_bone_structure | 0.59055937 |
| 115 | MP0009765_abnormal_xenobiotic_induced | 0.58168643 |
| 116 | MP0005165_increased_susceptibility_to | 0.58081926 |
| 117 | MP0001881_abnormal_mammary_gland | 0.57225961 |
| 118 | MP0005319_abnormal_enzyme/_coenzyme | 0.53055970 |
| 119 | MP0003279_aneurysm | 0.52276712 |
| 120 | MP0000609_abnormal_liver_physiology | 0.51108615 |
| 121 | MP0005076_abnormal_cell_differentiation | 0.49874031 |
| 122 | MP0000490_abnormal_crypts_of | 0.49624432 |
| 123 | MP0001915_intracranial_hemorrhage | 0.49298992 |
| 124 | MP0006054_spinal_hemorrhage | 0.49002357 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.20671417 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.18060862 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.74099790 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.09226478 |
| 5 | Chronic otitis media (HP:0000389) | 5.05463956 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.72884145 |
| 7 | Autoimmune thrombocytopenia (HP:0001973) | 4.58136734 |
| 8 | Mediastinal lymphadenopathy (HP:0100721) | 4.45456589 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.39804190 |
| 10 | Myositis (HP:0100614) | 4.18174193 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.09558752 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 4.06063762 |
| 13 | Increased IgM level (HP:0003496) | 3.87725728 |
| 14 | Vasculitis (HP:0002633) | 3.86194165 |
| 15 | Recurrent skin infections (HP:0001581) | 3.83103703 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.83099058 |
| 17 | Recurrent viral infections (HP:0004429) | 3.81523307 |
| 18 | Chronic diarrhea (HP:0002028) | 3.80932994 |
| 19 | Abnormality of the nasal mucosa (HP:0000433) | 3.80063200 |
| 20 | Orchitis (HP:0100796) | 3.75319475 |
| 21 | Malnutrition (HP:0004395) | 3.73991231 |
| 22 | Nasal polyposis (HP:0100582) | 3.70778580 |
| 23 | Vacuolated lymphocytes (HP:0001922) | 3.63308209 |
| 24 | Basal ganglia calcification (HP:0002135) | 3.58543051 |
| 25 | Recurrent bronchitis (HP:0002837) | 3.56984651 |
| 26 | Stomatitis (HP:0010280) | 3.49187617 |
| 27 | Gingivitis (HP:0000230) | 3.40843192 |
| 28 | Retrobulbar optic neuritis (HP:0100654) | 3.38211419 |
| 29 | Optic neuritis (HP:0100653) | 3.38211419 |
| 30 | Interstitial pulmonary disease (HP:0006530) | 3.37153155 |
| 31 | Hypergammaglobulinemia (HP:0010702) | 3.29112030 |
| 32 | Hydroxyprolinuria (HP:0003080) | 3.20746643 |
| 33 | Abnormality of proline metabolism (HP:0010907) | 3.20746643 |
| 34 | Cellulitis (HP:0100658) | 3.14813567 |
| 35 | Recurrent cutaneous fungal infections (HP:0011370) | 3.13026997 |
| 36 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.13026997 |
| 37 | Obstructive lung disease (HP:0006536) | 3.08986840 |
| 38 | Chronic obstructive pulmonary disease (HP:0006510) | 3.08986840 |
| 39 | Periodontitis (HP:0000704) | 3.01413333 |
| 40 | Chronic sinusitis (HP:0011109) | 3.01410299 |
| 41 | Thick nail (HP:0001805) | 3.00309627 |
| 42 | Increased cerebral lipofuscin (HP:0011813) | 2.94557474 |
| 43 | Spontaneous hematomas (HP:0007420) | 2.94498624 |
| 44 | Pustule (HP:0200039) | 2.94346441 |
| 45 | Hematochezia (HP:0002573) | 2.93953023 |
| 46 | Gastrointestinal infarctions (HP:0005244) | 2.89642503 |
| 47 | T lymphocytopenia (HP:0005403) | 2.88285424 |
| 48 | Tetraparesis (HP:0002273) | 2.85962352 |
| 49 | Pulmonary infiltrates (HP:0002113) | 2.81769685 |
| 50 | Abnormality of B cell number (HP:0010975) | 2.81248738 |
| 51 | Porencephaly (HP:0002132) | 2.79726861 |
| 52 | Meningitis (HP:0001287) | 2.76896376 |
| 53 | Hemoptysis (HP:0002105) | 2.75926742 |
| 54 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.75130012 |
| 55 | Hyperactive renin-angiotensin system (HP:0000841) | 2.69892885 |
| 56 | Colitis (HP:0002583) | 2.64848134 |
| 57 | Arterial thrombosis (HP:0004420) | 2.61370292 |
| 58 | Petechiae (HP:0000967) | 2.60007765 |
| 59 | Autoimmune hemolytic anemia (HP:0001890) | 2.56635434 |
| 60 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.54954248 |
| 61 | B lymphocytopenia (HP:0010976) | 2.53792858 |
| 62 | Abnormality of glycolipid metabolism (HP:0010969) | 2.53186288 |
| 63 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.53186288 |
| 64 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.53186288 |
| 65 | Urticaria (HP:0001025) | 2.52016663 |
| 66 | Leukocytosis (HP:0001974) | 2.50039561 |
| 67 | Emphysema (HP:0002097) | 2.49122737 |
| 68 | Osteomyelitis (HP:0002754) | 2.48789308 |
| 69 | Prostate neoplasm (HP:0100787) | 2.44778897 |
| 70 | Myocardial infarction (HP:0001658) | 2.43501307 |
| 71 | Gastrointestinal stroma tumor (HP:0100723) | 2.42137186 |
| 72 | IgA deficiency (HP:0002720) | 2.41871411 |
| 73 | Gingival bleeding (HP:0000225) | 2.41631633 |
| 74 | Encephalitis (HP:0002383) | 2.41536153 |
| 75 | Abnormality of T cell physiology (HP:0011840) | 2.40531569 |
| 76 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.39634726 |
| 77 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.39516188 |
| 78 | Eosinophilia (HP:0001880) | 2.38048220 |
| 79 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.37382124 |
| 80 | Glomerulonephritis (HP:0000099) | 2.36966364 |
| 81 | Thrombocytosis (HP:0001894) | 2.35980335 |
| 82 | Recurrent pneumonia (HP:0006532) | 2.33156456 |
| 83 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.32684680 |
| 84 | Osteolytic defects of the hand bones (HP:0009699) | 2.32684680 |
| 85 | Recurrent lower respiratory tract infections (HP:0002783) | 2.32360300 |
| 86 | Thin bony cortex (HP:0002753) | 2.32124811 |
| 87 | Inflammation of the large intestine (HP:0002037) | 2.30925143 |
| 88 | Bronchitis (HP:0012387) | 2.30230734 |
| 89 | Abnormality of complement system (HP:0005339) | 2.30076725 |
| 90 | Agammaglobulinemia (HP:0004432) | 2.29987177 |
| 91 | Complement deficiency (HP:0004431) | 2.28734121 |
| 92 | Loss of speech (HP:0002371) | 2.26471068 |
| 93 | Protuberant abdomen (HP:0001538) | 2.26147765 |
| 94 | Abnormality of T cells (HP:0002843) | 2.25386656 |
| 95 | Abnormality of T cell number (HP:0011839) | 2.24536015 |
| 96 | Nephritis (HP:0000123) | 2.24140914 |
| 97 | Fat malabsorption (HP:0002630) | 2.23743970 |
| 98 | Increased IgE level (HP:0003212) | 2.23461429 |
| 99 | Premature loss of primary teeth (HP:0006323) | 2.23304190 |
| 100 | Papilledema (HP:0001085) | 2.23111956 |
| 101 | Keratoconjunctivitis sicca (HP:0001097) | 2.22773909 |
| 102 | Gastrointestinal inflammation (HP:0004386) | 2.18231157 |
| 103 | Skin ulcer (HP:0200042) | 2.18103940 |
| 104 | Joint swelling (HP:0001386) | 2.16602844 |
| 105 | Abnormality of the pericardium (HP:0001697) | 2.15245225 |
| 106 | Esophageal varix (HP:0002040) | 2.13232805 |
| 107 | Dysostosis multiplex (HP:0000943) | 2.12822451 |
| 108 | Purpura (HP:0000979) | 2.12711056 |
| 109 | Chest pain (HP:0100749) | 2.12531317 |
| 110 | Bronchiectasis (HP:0002110) | 2.11372150 |
| 111 | Esophageal neoplasm (HP:0100751) | 2.08450127 |
| 112 | Neoplasm of head and neck (HP:0012288) | 2.08450127 |
| 113 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.08050044 |
| 114 | Joint hemorrhage (HP:0005261) | 2.07215778 |
| 115 | Peritonitis (HP:0002586) | 2.06819988 |
| 116 | Poor head control (HP:0002421) | 2.06452536 |
| 117 | Axonal loss (HP:0003447) | 2.06197771 |
| 118 | Abnormality of the prostate (HP:0008775) | 2.05467562 |
| 119 | Lymphopenia (HP:0001888) | 2.04934441 |
| 120 | Abnormality of the frontal sinuses (HP:0002687) | 2.04794700 |
| 121 | Epistaxis (HP:0000421) | 2.02253021 |
| 122 | Amyloidosis (HP:0011034) | 2.01865014 |
| 123 | Abnormality of the costochondral junction (HP:0000919) | 2.01297593 |
| 124 | Keratoconjunctivitis (HP:0001096) | 2.01246910 |
| 125 | IgG deficiency (HP:0004315) | 2.00694134 |
| 126 | Decreased circulating renin level (HP:0003351) | 2.00338970 |
| 127 | Spondylolisthesis (HP:0003302) | 2.00120643 |
| 128 | Mucopolysacchariduria (HP:0008155) | 1.99879383 |
| 129 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.99879383 |
| 130 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.96778918 |
| 131 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.93518028 |
| 132 | Abdominal distention (HP:0003270) | 1.92937223 |
| 133 | Abnormality of oral frenula (HP:0000190) | 1.92558381 |
| 134 | Hemorrhage of the eye (HP:0011885) | 1.91132260 |
| 135 | Cheilitis (HP:0100825) | 1.90644401 |
| 136 | Ileus (HP:0002595) | 1.90483156 |
| 137 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.89938715 |
| 138 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.89938715 |
| 139 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.89938715 |
| 140 | Abnormal glucose tolerance (HP:0001952) | 1.88083621 |
| 141 | Aortic aneurysm (HP:0004942) | 1.87962013 |
| 142 | Absent/shortened dynein arms (HP:0200106) | 1.86460325 |
| 143 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.86460325 |
| 144 | Aortic dissection (HP:0002647) | 1.86436503 |
| 145 | Widely patent fontanelles and sutures (HP:0004492) | 1.83916606 |
| 146 | Skin rash (HP:0000988) | 1.83866077 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TYK2 | 4.13108560 |
| 2 | MAP3K14 | 3.96333307 |
| 3 | TBK1 | 3.79987460 |
| 4 | IKBKE | 3.46443703 |
| 5 | PBK | 3.38311375 |
| 6 | JAK3 | 3.23712963 |
| 7 | BLK | 3.21495767 |
| 8 | JAK1 | 2.94855521 |
| 9 | KIT | 2.86195553 |
| 10 | RIPK4 | 2.82153044 |
| 11 | IRAK4 | 2.77963280 |
| 12 | MAP4K1 | 2.76574325 |
| 13 | FGFR4 | 2.48941603 |
| 14 | SCYL2 | 2.48252387 |
| 15 | IRAK3 | 2.26084858 |
| 16 | IKBKB | 2.16702859 |
| 17 | TXK | 2.09054968 |
| 18 | ACVR1B | 2.06251468 |
| 19 | ERN1 | 2.04959688 |
| 20 | PIM2 | 1.90830810 |
| 21 | MAP3K13 | 1.87355557 |
| 22 | EPHA2 | 1.74967605 |
| 23 | MAP3K3 | 1.71889363 |
| 24 | FGFR3 | 1.70468028 |
| 25 | CSK | 1.70343116 |
| 26 | MYLK | 1.51413000 |
| 27 | ZAP70 | 1.49254615 |
| 28 | CHUK | 1.43664175 |
| 29 | TAOK3 | 1.42069701 |
| 30 | MST4 | 1.41821736 |
| 31 | TIE1 | 1.37542525 |
| 32 | EPHB1 | 1.36145341 |
| 33 | TEC | 1.35745115 |
| 34 | NEK9 | 1.35062077 |
| 35 | EPHA3 | 1.30681933 |
| 36 | TGFBR2 | 1.29653659 |
| 37 | SYK | 1.24574788 |
| 38 | PRPF4B | 1.24546461 |
| 39 | TESK2 | 1.24066497 |
| 40 | DDR2 | 1.20995724 |
| 41 | LMTK2 | 1.17848838 |
| 42 | RPS6KA4 | 1.17291334 |
| 43 | LCK | 1.16304891 |
| 44 | HCK | 1.15504399 |
| 45 | PRKG2 | 1.15262418 |
| 46 | JAK2 | 1.11948149 |
| 47 | IRAK1 | 1.09329055 |
| 48 | CSF1R | 1.09070158 |
| 49 | MATK | 1.08827386 |
| 50 | BTK | 1.08211538 |
| 51 | NME2 | 1.04130390 |
| 52 | LYN | 1.01263380 |
| 53 | PIM1 | 0.99388026 |
| 54 | MARK3 | 0.99279105 |
| 55 | CDC42BPA | 0.97864844 |
| 56 | STK10 | 0.97411876 |
| 57 | MAP3K2 | 0.92881565 |
| 58 | TRPM7 | 0.92765788 |
| 59 | FES | 0.88902159 |
| 60 | MAP3K5 | 0.87121748 |
| 61 | RIPK1 | 0.86244668 |
| 62 | STK4 | 0.83853922 |
| 63 | FGR | 0.83297513 |
| 64 | EIF2AK2 | 0.83282564 |
| 65 | TESK1 | 0.82012421 |
| 66 | BMX | 0.78266273 |
| 67 | SIK2 | 0.77920279 |
| 68 | NLK | 0.77730498 |
| 69 | SIK3 | 0.75096015 |
| 70 | PIK3CG | 0.74467659 |
| 71 | KDR | 0.73147803 |
| 72 | TGFBR1 | 0.72883151 |
| 73 | PIK3CA | 0.69574615 |
| 74 | LRRK2 | 0.68412409 |
| 75 | MAP2K6 | 0.67165701 |
| 76 | MET | 0.63896252 |
| 77 | BMPR2 | 0.63594328 |
| 78 | TAOK2 | 0.62026648 |
| 79 | EGFR | 0.60339672 |
| 80 | INSRR | 0.60072593 |
| 81 | ABL2 | 0.60043638 |
| 82 | IRAK2 | 0.59428731 |
| 83 | MAP3K11 | 0.58228688 |
| 84 | ITK | 0.57763503 |
| 85 | PRKD2 | 0.56255560 |
| 86 | STK24 | 0.54554186 |
| 87 | DMPK | 0.53987197 |
| 88 | ABL1 | 0.53678022 |
| 89 | CAMK1D | 0.52183016 |
| 90 | PDGFRA | 0.51062628 |
| 91 | MAPKAPK3 | 0.50158122 |
| 92 | PAK4 | 0.49791880 |
| 93 | FLT3 | 0.49670624 |
| 94 | MST1R | 0.49557202 |
| 95 | PRKCD | 0.48907457 |
| 96 | STK38 | 0.47970410 |
| 97 | TTN | 0.47488997 |
| 98 | HIPK2 | 0.46051454 |
| 99 | PRKCQ | 0.45996554 |
| 100 | TAOK1 | 0.43627017 |
| 101 | MAP2K3 | 0.43241238 |
| 102 | MAPK11 | 0.42620333 |
| 103 | PDPK1 | 0.41733095 |
| 104 | ADRBK2 | 0.41195775 |
| 105 | PTK2B | 0.39933975 |
| 106 | PDK1 | 0.39075660 |
| 107 | MAPK7 | 0.38596200 |
| 108 | IGF1R | 0.37013970 |
| 109 | PKN2 | 0.36856381 |
| 110 | PTK6 | 0.36546768 |
| 111 | SIK1 | 0.36494512 |
| 112 | CLK1 | 0.35576424 |
| 113 | MELK | 0.35224341 |
| 114 | MAP3K10 | 0.34968850 |
| 115 | CDK6 | 0.34776116 |
| 116 | MAP3K6 | 0.33317404 |
| 117 | ARAF | 0.32034798 |
| 118 | STK3 | 0.32030922 |
| 119 | RPS6KA5 | 0.31965648 |
| 120 | GRK7 | 0.31623547 |
| 121 | RPS6KA6 | 0.29840649 |
| 122 | DAPK3 | 0.28546808 |
| 123 | TRIB3 | 0.26738234 |
| 124 | PDGFRB | 0.25569513 |
| 125 | MAPK4 | 0.24923007 |
| 126 | CAMKK2 | 0.24795646 |
| 127 | YES1 | 0.24523012 |
| 128 | MAP3K12 | 0.24155434 |
| 129 | MOS | 0.24021622 |
| 130 | MAPKAPK2 | 0.23742115 |
| 131 | FYN | 0.23251421 |
| 132 | MAP3K1 | 0.21871150 |
| 133 | PRKCH | 0.21360367 |
| 134 | GRK6 | 0.20978005 |
| 135 | INSR | 0.20681776 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.28186365 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.03458991 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.00818190 |
| 4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.00335056 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.99966125 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.91803337 |
| 7 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.77741726 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.70202579 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.63443965 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.44364762 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 2.31679573 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 2.27671605 |
| 13 | Influenza A_Homo sapiens_hsa05164 | 2.26838588 |
| 14 | Malaria_Homo sapiens_hsa05144 | 2.24062354 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.22488660 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.21338528 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.15972379 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 2.09202236 |
| 19 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.09066568 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.05270289 |
| 21 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.00206492 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.89566703 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.83957349 |
| 24 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.80365574 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.78726682 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.76100509 |
| 27 | Asthma_Homo sapiens_hsa05310 | 1.73597371 |
| 28 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.73138901 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.66049059 |
| 30 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.64355762 |
| 31 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.62359057 |
| 32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.59425138 |
| 33 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.53167310 |
| 34 | Salmonella infection_Homo sapiens_hsa05132 | 1.50927499 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.47252333 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.46586031 |
| 37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.45139151 |
| 38 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.41118940 |
| 39 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.40524292 |
| 40 | Hepatitis C_Homo sapiens_hsa05160 | 1.38302383 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.33332953 |
| 42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.33008218 |
| 43 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.30558498 |
| 44 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.22594209 |
| 45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.21485849 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 1.20855734 |
| 47 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.19890182 |
| 48 | Shigellosis_Homo sapiens_hsa05131 | 1.19836740 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.18273162 |
| 50 | Lysosome_Homo sapiens_hsa04142 | 1.14999179 |
| 51 | Histidine metabolism_Homo sapiens_hsa00340 | 1.09801091 |
| 52 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.09729794 |
| 53 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.09625791 |
| 54 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.06739718 |
| 55 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.06427977 |
| 56 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.06396198 |
| 57 | Phagosome_Homo sapiens_hsa04145 | 1.06314756 |
| 58 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.04337573 |
| 59 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.99986767 |
| 60 | Retinol metabolism_Homo sapiens_hsa00830 | 0.97446482 |
| 61 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.92389275 |
| 62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.91900533 |
| 63 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.91516642 |
| 64 | Galactose metabolism_Homo sapiens_hsa00052 | 0.91457931 |
| 65 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.90412599 |
| 66 | Other glycan degradation_Homo sapiens_hsa00511 | 0.88802312 |
| 67 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.84121229 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.83732535 |
| 69 | Amoebiasis_Homo sapiens_hsa05146 | 0.82961085 |
| 70 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.82542211 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.80387436 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.79539946 |
| 73 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77654233 |
| 74 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.76614201 |
| 75 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.74861036 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71413775 |
| 77 | Prion diseases_Homo sapiens_hsa05020 | 0.70442939 |
| 78 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.69700005 |
| 79 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.69004698 |
| 80 | Platelet activation_Homo sapiens_hsa04611 | 0.63222966 |
| 81 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.60465489 |
| 82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.60334909 |
| 83 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.59211964 |
| 84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57075899 |
| 85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57056494 |
| 86 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56292758 |
| 87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56160524 |
| 88 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53958825 |
| 89 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.53459046 |
| 90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53401222 |
| 91 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.52668268 |
| 92 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.52241437 |
| 93 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51795375 |
| 94 | Bile secretion_Homo sapiens_hsa04976 | 0.50568810 |
| 95 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50493619 |
| 96 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44884891 |
| 97 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.44759902 |
| 98 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.43857203 |
| 99 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40756513 |
| 100 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.40163706 |
| 101 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.39704125 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.39075446 |
| 103 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.37570976 |
| 104 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.36277147 |
| 105 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.34560029 |
| 106 | HTLV-I infection_Homo sapiens_hsa05166 | 0.33302713 |
| 107 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33231194 |
| 108 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.32757176 |
| 109 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.31976596 |
| 110 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.31378805 |
| 111 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.31378267 |
| 112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.24047720 |
| 113 | Focal adhesion_Homo sapiens_hsa04510 | 0.22758349 |
| 114 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.21999227 |
| 115 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.21825144 |
| 116 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.20853216 |
| 117 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.17650358 |
| 118 | Proteasome_Homo sapiens_hsa03050 | 0.15405449 |
| 119 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.14347581 |
| 120 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.14265038 |
| 121 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.14060593 |
| 122 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.13798892 |
| 123 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.12333944 |
| 124 | ABC transporters_Homo sapiens_hsa02010 | 0.12288442 |
| 125 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.11679241 |
| 126 | Prostate cancer_Homo sapiens_hsa05215 | 0.11070050 |
| 127 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.09177104 |
| 128 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.08441003 |
| 129 | Mineral absorption_Homo sapiens_hsa04978 | 0.07759150 |
| 130 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.07617970 |
| 131 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.06557245 |
| 132 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.05457197 |

